Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
CHOLERA VACCINE, ORAL |
Shancol |
Cholera |
CH-WC-02 |
||
CLOSTRIDIUM DIFFICILE TOXOID VACCINE |
Not yet identified |
Clostridium Difficile |
CDI19 (DFI13360) |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-008 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-009 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-010 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-011 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-012 |
||
CLOSTRIDIUM DIFFICILE VACCINE |
Not yet identified |
Clostridium Difficile |
H-030-014 |
||
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B [RECOMBINANT] |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR504 |
||
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B (RECOMBINANT) |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR505 (V419-005) |
||
US: DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS VACCINE ADSORBED, INACTIVATED POLIOVIRUS, HAEMOPHILUS B CONJUGATE [MENINGOCOCCAL PROTEIN CONJUGATE] AND HEPATITIS B [RECOMBINANT] |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
PR506 (V419-006) |
||
DTAP |
Tripacel® |
Diphtheria; Tetanus; Pertussis |
P3T06 |
||
DTAP |
Daptacel® |
Diphtheria; Tetanus; Pertussis |
P3T10 |
||
DTAP |
Daptacel® |
Diphtheria; Tetanus; Pertussis |
P3T11 |
||
DTAP-IPV |
COVAXiS®; REPEVAX® |
DDiphtheria; Tetanus; Pertussis; Poliomyelitis |
PERTIMMUN06 |
||
DTAP-HIB VACCINE |
Actacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
C5A06 |
||
DTAP-IPV-HB-PRP~T HEXAVALENT VACCINE |
Hexaxim® |
Diphtheria; Tetanus; acellular Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L00052 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L02 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L04 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L10 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L11 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L12 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L15 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L16 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L17 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L21 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L22 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L24 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L26 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L27 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L28 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L31 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L33 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim®/Hexacima®/Hexyon® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L35 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L35 |
Not yet |
|
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L38 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L39 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L40 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L44 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L45 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L47 |
Not yet |
|
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
A3L49 |
||
DTAP-IPV- HEP B-HIB VACCINE |
Hexaxim® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
HXM01C |
||
DTAP-HEP B-HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL201 |
||
DTAP-HEP B-HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL203 |
||
DTAP-HEP B-HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL204 |
||
DTAP-HEP B-HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
AL205 |
||
DTAP-IPV VACCINE ((DIPHTHERIA AND TETANUS TOXOIDS AND ACELLULAR PERTUSSIS ADSORBED AND INACTIVATED POLIOVIRUS VACCINE) |
Quadracel® |
Tetanus; Diphtheria; Pertussis; Poliomyelitis |
M5I02 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I28 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I29 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I34 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I41 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I42 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I43 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I49 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I57 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I59 |
||
DTAP-IPV/HIB VACCINE |
Pentaxim® Pentavac® |
Pertussis; Diphtheria; poliomyelitis; Tetanus; Haemophilus Influenza type B |
E2I60 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A07 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A08 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A10 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A11 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A15 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A16 |
||
DTAP-IPV/HIB VACCINE |
Pentacel™ |
Diphtheria; Tetanus; Pertussis; Poliomyelitis; Haemophilus Influenzae type B |
M5A17 |
Not yet |
|
DTAP-IPV-HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I15 |
||
DTAP-IPV-HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I16 |
||
DTAP-IPV-HIB VACCINE |
Pediacel® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
A5I19 |
||
DTAP-IPV/HIB VACCINE |
Not yet identified |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
J2I02 (EFC13640) |
||
DTAP-IPV-HIB AND DTAP-IPV- HEP B-HIB VACCINES |
Not yet identified; |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis |
PRI02C |
||
DTAP-IPV VACCINE; DTIPV VACCINE |
REPEVAX®; |
Diphtheria; Tetanus; Pertussis;Poliomyelitis |
RPV04C |
||
DTAP-IPV- HEP B-HIB VACCINE |
Vaxelis® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B |
V419-008 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
DTPwHB-Hib-2007-0200 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
DTPwHB-HibPMS-2007-010 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
SH501 |
|
|
DTwP-HepB-Hib-IPV |
SHAN6™ |
diphtheria, tetanus, pertussis, hepatitis B, invasive Haemophilus influenzae type B and poliomyelitis |
SH600001 |
||
DTwP-HepB-Hib-IPV |
SHAN6™ |
diphtheria, tetanus, pertussis, hepatitis B, invasive Haemophilus influenzae type B and poliomyelitis |
SH600002 |
||
DTWP-HEP B-HIB VACCINE |
SHAN 5® |
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Hepatitis B |
SH505 |
|
|
DTwP-HepB-Hib-IPV |
SHAN6™ |
diphtheria, tetanus, pertussis, hepatitis B, invasive Haemophilus influenzae type B and poliomyelitis |
SH600003 |
||
DTWP-HEPB-HIB-IPV |
SHAN6™ |
diphtheria, tetanus, pertussis, hepatitis B, invasive Haemophilus influenzae type B and poliomyelitis |
SH600004 |
||
DTwP-HepB-Hib-IPV |
SHAN6™ |
diphtheria, tetanus, pertussis, hepatitis B, invasive Haemophilus influenzae type B and poliomyelitis |
SH600009 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
HEPATITIS A VACCINE |
AVAXIM 80U Pediatric Vaccine |
Hepatitis A |
HAF65 |
||
HEPATITIS A VACCINE |
AVAXIM 160U |
Hepatitis A |
HAF78 |
||
HEPATITIS A VACCINE |
Avaxim® 80U Pediatric vaccine |
Hepatitis A |
HAF85 |
||
HEPATITIS A VACCINE |
Avaxim® 80U Pediatric vaccine |
Hepatitis A |
HAF87 |
||
HEPATITIS B VACCINE |
HBVAXPRO® |
Hepatitis B |
HXV01C |
||
HEPATITIS B VACCINE |
HBVAXPRO® |
Hepatitis B |
HXV02C |
||
HEPATITIS B VACCINE |
HBVAXPRO® |
Hepatitis B |
rHB01C |
||
herpes simplex virus type 2 |
Not marketed |
Genital Herpes |
HSV15 |
||
HUMAN PAPILLOMAVIRUS VACCINE |
GARDASIL®9 |
Human papillomavirus infection |
GDS07C |
GENERIC NAME |
TRADE NAME (S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV13 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV17 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV25 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV26 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV29 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV30 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV31 |
Not yet |
|
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV34 |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV35 (EFC12403) |
||
INACTIVATED POLIOVIRUS VACCINE |
Imovax Polio®; Ipol® |
Poliomyelitis |
IPV46 (EFC13614) |
||
INFLUENZA VIRUS VACCINE - CELL BASED |
Not yet identified |
Influenza infection |
GCE03 |
||
INFLUENZA-A VACCINE (RECOMBINANT M2E) |
ACAM FLU-A |
Influenza infection |
H-261-001 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC01 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC02 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC04 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC05 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC07 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC12 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC13 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC15 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC17 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC18 |
||
JAPANESE ENCEPHALITIS VACCINE |
Imojev® |
Japanese Encephalitis |
JEC22 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-004 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-005 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-006 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-007 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-008 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-009 |
||
JAPANESE ENCEPHALITIS VACCINE - LIVE ATTENUATED |
Imojev® |
Japanese Encephalitis |
H-040-010 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
LIVE ATTENUATED STABILIZED YELLOW FEVER VACCINE |
Stamaril® |
Yellow Fever Virus |
STA10 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE |
ProQuad® |
Measles, Mumps, Rubella, and Varicella |
X06-MMRV-302 |
||
MEASLES, MUMPS AND RUBELLA VACCINE |
ProQuad® |
Measles, Mumps and Rubella |
MRV02C |
||
MELANOMA MULTI-ANTIGEN THERAPEUTIC VACCINE - ALVAC(2) |
Not yet identified |
Metastatic Melanoma |
MEL11 |
||
MENINGOCOCCAL AC POLYSACCHARIDE VACCINE |
PS Meningococcal A+C® |
Meningococcal meningitis |
MPS01 |
||
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Not yet identified |
Smallpox |
H-249-001 |
Not yet |
|
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Not yet identified |
Smallpox |
H-249-002 |
Not yet |
|
MODIFIED VACCINIA ANKARA (MVA) SMALLPOX VACCINE |
Not yet identified |
Smallpox |
H-249-004 |
Not yet |
|
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF04 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF14 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF15 |
||
MONOVALENT SUBVIRION A/H1N1 INFLUENZA VACCINE |
Influenza A (H1N1) 2009 monovalent vaccine |
Influenza infection (Swine-origin A/H1N1) |
FUF16 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
NA |
NA |
Zika Virus Disease |
VAG00001 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
ORAL CHOLERA VACCINE |
Shanchol® |
Cholera |
SHC02 |
||
ORAL CHOLERA VACCINE |
Shanchol® |
Cholera |
SHC03 |
||
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
PNEUMOCOCCAL POLYSACCHARIDE VACCINE |
Pneumo 23® |
Pneumococcal Infections |
PNA19 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR01 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR02 |
Not yet |
|
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR05 |
||
PNEUMOCOCCAL PROTEIN VACCINE |
Not yet identified |
Pneumococcal Infections |
PPR06 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV01 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV02 |
Not yet |
|
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV04 |
Not yet |
|
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV06 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV08 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV11 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not marketed |
Rabies |
VRV13 |
||
PURIFIED VERO RABIES VACCINE - SERUM FREE |
Not yet identified |
Rabies |
VRV00014 |
GENERIC NAME |
TRADE NAME |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM01 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM02 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM04 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM05 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM07 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM09 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM10 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM11 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM14 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra™ |
Influenza infection |
GQM00016 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
VaxigripTetra |
Influenza infection |
FSQ02 |
||
Quadrivalent Influenza Vaccine |
Fluzone, Efluelda |
Influenza infection |
EFC15150 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00008 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00011 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD00013 |
||
HIGH-DOSE QUADRIVALENT INFLUENZA VACCINE |
Fluzone® High Dose Quadrivalent Vaccine |
Influenza infection |
QHD04 |
||
High-Dose Quadrivalent Influenza Vaccine |
Not marketed |
Influenza |
QHD00023 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC00097 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC00101 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC00102 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC51 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC52 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC55 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC56 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC57 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC58 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC71 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC73 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC85 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC88 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
GRC90 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV03 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV04 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV06 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Quadrivalent |
Influenza infection |
QIV08 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
QHD00028 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE - INTRADERMAL |
Fluzone® QIV-ID |
Influenza infection |
QID01 |
||
QUADRIVALENT INACTIVATED INFLUENZA VACCINE - INTRADERMAL |
Fluzone® QIV-ID |
Influenza infection |
QID02 |
||
QUADRIVALENT MENINGOCOCCAL ACYW POLYSACCHARIDE VACCINE |
Menomune® |
Meningococcal meningitis |
MPT01 |
||
QUADRIVALENT MENINGOCOCCAL ACYW POLYSACCHARIDE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
EFC16335 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET32 |
Not yet |
|
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET39 |
NCT01049035 |
Not yet |
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET59 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET35 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET43 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET44 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET49 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET50 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET51 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET54 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET56 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET57 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MET62 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MEQ00065 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
MenQuadfiTM |
Meningococcal meningitis |
MEQ00066 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA15 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA16 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA17 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA19 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA21 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA23 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA26 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA29 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA30 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA35 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA37 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA38 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA40 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA43 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA44 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA47 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA48 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA51 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA52 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA55 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA57 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA61 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA62 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA64 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA70 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA71 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA73 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA75 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA76 (SFY12080) |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA77 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA79 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA89 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA90 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA92 |
||
QUADRIVALENT MENINGOCOCCAL ACYW CONJUGATE VACCINE |
Menactra® |
Meningococcal meningitis |
MTA00093 |
||
QUADRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC12 |
||
QUADRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC16 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
RABIES VACCINE |
Verorab® |
Rabies |
VAJ00001 |
||
RABIES VACCINE (PURIFIED VEROCELL) |
Verorab® |
Rabies |
RAB28 |
||
RABIES VACCINE (PURIFIED VEROCELL) |
Verorab® |
Rabies |
RAB40 |
||
ROTAVIRUS VACCINE |
RotaTeq® |
Rotavirus infection |
S06-ROT-304 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
SARS-COV-2 ADJUVANTED RECOMBINANT PROTEIN VACCINE |
Not Marketed |
COVID-19 (Healthy Volunteers) |
VAT00008 |
Not yet |
|
Shenzhen quadrivalent influenza vaccine |
Not marketed |
Influenza infection |
FSQ01 |
||
SMALLPOX VACCINE |
Not yet identified |
Smallpox; Poxvirus Infection |
VVL04 |
||
SMALLPOX VACCINE |
Not yet identified |
Smallpox; Poxvirus Infection |
VVL05 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF01 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF07 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF08 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF09 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF11 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF14 |
||
SWINE A/H1N1 INFLUENZA VACCINE (SPLIT VIRION, INACTIVATED) |
Panenza™ |
Influenza infection |
GPF18 |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
TDAP VACCINE |
Not yet identified |
Tetanus; Diphtheria; Pertussis |
ADC01 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TC9704-LT |
||
tetanus, diphtheria, acellular pertussis vaccine (Tdap) |
Adacel® |
Pertussis |
TD500059 |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD506-LT |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD508 |
||
TDAP |
Adacel® / Covaxis® |
Tetanus; Diphtheria; Pertussis |
TD511 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD512 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD515 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td516 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td517 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td518 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td519 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td521 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td526 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td527 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td528 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td532 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td533 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td536 (EFC12579) |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td537 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td540 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
Td551 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9707-LT |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9805-LT |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9809 |
||
TDAP |
Adacel® |
Tetanus; Diphtheria; Pertussis |
TD9809-LT |
||
TDAP / TDAP-IPV |
Covaxis® Polio Repevax® |
Pertussis; Diphtheria; Tetanus; Poliomyelitis |
TRI05 |
||
TDAP-IPV |
Adacel® Polio |
Tetanus; Diphtheria; Pertussis; Polio |
Td525 |
||
TETANUS AND DIPHTHERIA TOXOIDS ADSORBED VACCINE |
Tenivac™ |
Diphtheria; Tetanus |
TDC01 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD01 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD02 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD04 |
|
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD05 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD06 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD08 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD10 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD11 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD12 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD13 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD14 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD15 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD17 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD22 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD23 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD24 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD28 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD29 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD30 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD32 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD33 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD34 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD35 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD47 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD50 |
Not yet |
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD51 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD56 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD57 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD59 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD63 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD64 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD65 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD66 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD67 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
CYD71 |
||
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
DNG10 |
Not yet |
|
CYD DENGUE VACCINE |
Dengvaxia® |
Dengue / Dengue Hemorrhagic Fever |
DNG15 |
Not yet |
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID04 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID07 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID21 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID30 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID31 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® Intradermal |
Influenza infection |
FID33 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM01 |
|
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM05 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM07 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM09 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
FIM12 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® High Dose |
Influenza infection |
QHD01 |
Not yet |
|
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Not yet identified |
Influenza infection |
FST01 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Not yet identified |
Influenza infection |
FST02 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID02 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID15 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID16 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID17 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID18 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID23 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID25 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID26 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID33 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID34 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Intanza® / IDflu® |
Influenza infection |
GID37 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA02 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA04 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA11 |
||
A/H5N1 INFLUENZA VACCINE |
Emerflu™ |
Influenza infection |
GPA12 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC16 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC17 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC20 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC21 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC25 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC26 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC27 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC29 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC32 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC34 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC35 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC37 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC38 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC40 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC41 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC43 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC48 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC49 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Fluzone® |
Influenza infection |
GRC50 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT63 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT82 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT83 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT86 |
||
TRIVALENT INACTIVATED INFLUENZA VACCINE |
Vaxigrip® |
Influenza infection |
GRT90 |
||
TRIVALENT RECOMBINANT INFLUENZA VACCINE |
FluBlok® |
Influenza |
PSC04 |
||
TYPHOID VI POLYSACCHARIDE VACCINE |
Typhim Vi® |
Typhoid Fever |
TYP31 (SFY12079) |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
VARICELLA VIRUS VACCINE - LIVE ATTENUATED |
Zostavax® |
Varicella |
VBK12 |
||
VARICELLA VIRUS VACCINE - LIVE ATTENUATED |
Zostavax® |
Varicella |
ZTV03C |
GENERIC NAME |
TRADE NAME(S) |
CONDITION(S) |
STUDY CODE |
ACCESS TO STUDY / PROTOCOL |
ACCESS TO RESULTS |
---|---|---|---|---|---|
WEST NILE VACCINE - CHIMERIVAX-WN02 |
Not yet identified |
West Nile Fever |
H-244-003 |
||
WEST NILE VACCINE - CHIMERIVAX-WN02 |
Not yet identified |
West Nile Fever |
H-244-004 |
||